Jamie L. Reynoso
CIK 1839066 · CEO, Medicare Advantage · last filed 2026-10-20
Jamie L. Reynoso is a CEO, Medicare Advantage who has filed 99 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing shows the insider sold $17.9K of CLOV on Oct 20, 2026. Across all open-market trades the lifetime net is −$757.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $13.1M across reported positions. 88 SEC filings were submitted jointly with CLOVER HEALTH INVESTMENTS, CORP. /DE.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CLOV price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
725 COOL SPRINGS BLVD., SUITE 320
FRANKLIN, TN 37067
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CLOV | CEO, Medicare Advantage | 2,770,351 | $4.71 | $13.06M | -$757.8K | 72 | 2026-10-20 |
| CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOVW) Delisted | Chief Operating Officer | 220,820 | $2.02 | $446.1K | $0 | 2 | 2021-07-20 |
Recent Filings
99 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-10-20 | CLOV | Sell (S) | −4,066 | -$17.9K | EDGAR |
| 2026-10-19 | CLOV | Notice (144) | −4,066 | -$18.2K | EDGAR |
| 2026-10-19 | CLOV | Sell (S) | −18,273 | -$85.5K | EDGAR |
| 2026-10-15 | CLOV | Notice (144) | −17,858 | -$83.6K | EDGAR |
| 2026-10-07 | CLOV | Notice (144) | −2,006 | -$9.2K | EDGAR |
| 2026-10-07 | CLOV | Sell (S) | −2,006 | -$9.3K | EDGAR |
| 2026-10-05 | CLOV | Sell (S) | −8,750 | -$38.7K | EDGAR |
| 2026-10-05 | CLOV | Notice (144) | −8,706 | -$40.7K | EDGAR |
| 2026-09-18 | CLOV | Sell (S) | −1,921 | -$8.8K | EDGAR |
| 2026-09-17 | CLOV | Notice (144) | −1,921 | -$8.8K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.